On Friday, Sanofi (NASDAQ: SNY), the French drug maker, posted stronger earnings growth than analysts had expected in the third […]
Sanofi (NASDAQ: SNY) Posts Q3 Profit Beat on Early Start of Vaccine Sales Read More »
LONDON – Buyout fund CD&R’s keenly awaited 16 billion euro ($17.36 billion) deal to take control of Sanofi’s (NASDAQ: SNY)
Analysis: Dealmakers Expect Bigger European Private Equity Buyouts and More of Them Read More »
PARIS – Sanofi (NASDAQ: SNY) agreed on terms to sell a controlling stake in its consumer health unit Opella to
Sanofi Agrees to Sale Terms for Consumer Health Unit, Say French Government Sources Read More »
PARIS – On Monday, Sanofi (NASDAQ: SNY), the French drugmaker, said it had entered exclusive talks to sell a 50%
Sanofi (NASDAQ: SNY) in Exclusive Talks with CD&R to Sell Consumer Health Unit Opella Read More »
PARIS – On Thursday, Sanofi (NASDAQ: SNY), the French drugmaker, said it was “surprised” by a renewed, higher offer for
Sanofi “Surprised” as PAI Partners Raises Bid for Opella Unit Read More »
PARIS – The French government needs guarantees from drugmaker Sanofi (NASDAQ: SNY) that production of its popular Doliprane painkiller will
France Seeks Job Guarantees from Sanofi Over Doliprane Painkiller Production Read More »
Sanofi (NASDAQ: SNY) is closing in on a deal to sell its consumer health unit for about 15 billion euros
Sanofi (NASDAQ: SNY) Nears $16 Billion Sale of Consumer Health Unit to CD&R, Source Says Read More »
GSK (NYSE: GSK), Sanofi (NASDAQ: SNY), and CSL Ltd have secured $72 million from the U.S. government to ramp up
Sanofi, GSK, CSL Secure $72 Million Funding to Expand US Bird Flu Vaccine Supply Read More »
On Friday, Recordati, the Italian pharma group, said it would buy from Sanofi (NASDAQ: SNY) the global rights to a
Recordati and Sanofi Shares Rise Following $825 Million Drug Rights Deal Read More »
Copyright © 2024 abbonews.com
